This collection
is approved as amended by FDA's revisions of 7/9/01 and 7/11/01 and
on the following condition. If FDA determines that modifications to
the collection are necessary during the course of the pilot, FDA
will notify OMB of those changes in advance and seek OMB's prior
approval. FDA shall notify OMB of the changes through a memorandum,
explaining the need for such changes. Once approved, OMB will amend
the file accordingly. FDA should also send OMB an update as to the
progress of the pilot at least once annually and prior to the
development of the regulation.
Inventory as of this Action
Requested
Previously Approved
07/31/2004
07/31/2004
1,245
0
0
934
0
0
0
0
0
This pilot includes: implementing an
electronic version of the portions of the 3500A form used by user
facilities to report adverse events occurring with medical devices
and adding additional voluntary questions to the data collection.
Participation in this pilot will be voluntary and will initially
include 25 facilities. It is anticipated that the number of
voluntary participants will increase to approximately 250
facilities.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.